# Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung Cancer

> **NCT00329472** · PHASE3 · WITHDRAWN · sponsor: **Samsung Medical Center**

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** gemcitabine, cisplatin

## Key facts

- **NCT ID:** NCT00329472
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-04
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** poor enrollment
- **Last updated:** 2010-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00329472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00329472, "Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00329472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*